Forgot your password?

Forgot your username?

The Technology Corner: Disruptive Technology for Prostate Cancer, Part I

In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general. Each day we will showcase a new emerging company, providing an eloquently detailed description of the intriguing technology....

Katie McHugh and Leon Marucchi of MPR Associates Discuss The Value of Concurrent Design and DFM

The final interview in our MPR series is with Leon Marucchi, Director of Industrial Design and Katie McHugh, a design engineer at the international consulting firm. Below they discuss concurrent design and design from manufacture and the tremendous value it provides in bringing a device to...

Healthcare’s Digital Revolution: Part I

Just as smartphones are replacing books within the personal realm, electronic tablets are quickly taking the place of paper in doctors’ offices, and are doing so on a global scale. Healthcare is steadily moving in the direction of digitization, and electronic health records (EHRs) and tablets have already...

The Future of Healthcare: Part II, The Waiting Room of Tomorrow

In Part II of our expert series on the future of healthcare and The Patient, OneMedPlace sits down with Dr. Cynthia Haines to discuss the digitization of the waiting room. We are seeing a new push by healthcare providers to better educate patients, and the development of various tools to do so. At home,...

OneMedForum NY 2012 Sponsor Aptiv Solutions Educates the Market on Adaptive Clinical Trials

Aptiv Solutions is a full-service international CRO with proven expertise in supporting global clinical trials for biopharmaceutical and medical device companies. Their trials span the development lifecycle from first-in-human through regulatory approval and beyond. As a sponsor for OneMedForum New York...

Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure

Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) today announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition with a significant increase in her red cells, white cells and platelets following...

« Older Entries